CTL inducing vaccines, Recombinant Adeno-associated Virus Vaccine (rAAV) and Modified Vaccinia Ankara (MVA) are being developed for

Ever since 1987, more than 30 HIV candidate vaccines have been tested in Clinical trials Phases I/II; Some of them are: – AIDSVAX (gp 120 based vaccine): only vaccine in Phase III trials – Cytotoxic T-Lymphocytes (CTL) Inducing vaccine – Recombinant adeno- associated virus (rAAV) vaccine – Modified Vaccinia ankara (mVA) vaccine – Subunit vaccine